COVID-19 convalescent plasma donor recruitment experience from the perspective of a hospital transfusion medicine service
- PMID: 33990952
- PMCID: PMC8242920
- DOI: 10.1111/trf.16448
COVID-19 convalescent plasma donor recruitment experience from the perspective of a hospital transfusion medicine service
Conflict of interest statement
The authors have disclosed no conflicts of interest.
Figures
Comment on
-
Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults.N Engl J Med. 2021 Feb 18;384(7):610-618. doi: 10.1056/NEJMoa2033700. Epub 2021 Jan 6. N Engl J Med. 2021. PMID: 33406353 Free PMC article. Clinical Trial.
References
-
- CDC. COVID data tracker. 2021. https://covid.cdc.gov/covid‐data‐tracker/#cases_casesper100klast7days. Accessed 5 Jan 2021.
-
- Center for Biologics Evaluation and Research, U.S. F. and D. A. Investigational COVID‐19 convalescent plasma guidance for industry. 2020. Washington, DC: U.S. Department of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research. https://www.notifylibrary.org/sites/default/files/Investigational‐COVID‐.... Accessed 20 Mar 2021.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
